Efficacy of Inferrin<sup>TM</sup> and Lactoferrin on Symptoms of Irritable Bowel Syndrome in Otherwise Healthy Adults: A Randomised, Double-Blind, Placebo-Controlled Study — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Efficacy of Inferrin<sup>TM</sup> and Lactoferrin on Symptoms of Irritable Bowel Syndrome in Otherwise Healthy Adults: A Randomised, Double-Blind, Placebo-Controlled Study
Background: Irritable bowel syndrome affects one in five Australians, with abdominal pain as one of the main symptoms. Lactoferrin, found in milk, is known for its anti-inflammatory properties, and the development of a novel microencapsulated form, Inferrin TM , may be useful in the treatment of irritable bowel syndrome symptoms. The current study aimed to study the effectiveness of Inferrin TM compared to lactoferrin and a placebo on irritable bowel syndrome symptoms. Methods: Sixty-eight male and female participants over 18 years of age were recruited to complete 8 weeks of supplementation with either Inferrin TM , lactoferrin, or a matched placebo. Outcomes were measured at baseline, week 4, and week 8. Results: There was a decrease from baseline across all groups in IBS symptom severity at weeks 4 and 8, as well as improvements in QOL scores. Lactoferrin and Inferrin TM groups had a significant reduction from baseline to week 8 in weekly stool frequency. Conclusions: Overall, lactoferrin and Inferrin TM appeared to have an effect in decreasing symptoms of IBS and weekly stool frequency.
Wang, B., Timilsena, Y.P., Blanch, E. and Adhikari, B. (2019) Lactoferrin: Structure, Function, Denaturation and Digestion. Critical Reviews in Food Science and Nutrition, 59, 580-596. https://doi.org/10.1080/10408398.2017.1381583
Adlerova, L., Bartoskova, A. and Faldyna, M.J.V.M. (2008) Lactoferrin: A Review. Veterinarni Medicina., 53, 457-468. https://doi.org/10.17221/1978-VETMED
Tolone, S., Pellino, V., Vitaliti, G., Lanzafame, A. and Tolone, C. (2012) Evaluation of Helicobacter Pylori Eradication in Pediatric Patients by Triple Therapy plus Lactoferrin and Probiotics Compared to Triple Therapy Alone. Italian Journal of Pediatrics, 38, Article No. 63. https://doi.org/10.1186/1824-7288-38-63
Levay, P.F. and Viljoen, M. (1995) Lactoferrin: A General Review. Haematologica, 80, 252-267.
Didari, T., Mozaffari, S., Nikfar, S. and Abdollahi, M. (2015) Effectiveness of Probiotics in Irritable Bowel Syndrome: Updated Systematic Review with Meta-Analysis. World Journal of Gastroenterology, 21, 3072-3084. https://doi.org/10.3748/wjg.v21.i10.3072
Holtmann, G.J., Ford, A.C. and Talley, N.J. (2016) Pathophysiology of Irritable Bowel Syndrome. The Lancet Gastroenterology & Hepatology, 1, 133-146. https://doi.org/10.1016/S2468-1253(16)30023-1
Rosa, L., Cutone, A., Lepanto, M.S., Paesano, R. and Valenti, P. (2017) Lactoferrin: A Natural Glycoprotein Involved in Iron and Inflammatory Homeostasis. International Journal of Molecular Sciences, 18, Article No. 1985. https://doi.org/10.3390/ijms18091985
Saha, L. (2014) Irritable Bowel Syndrome: Pathogenesis, Diagnosis, Treatment, and Evidence-Based Medicine. World Journal of Gastroenterology, 20, 6759-6773. https://doi.org/10.3748/wjg.v20.i22.6759
Liu, N., Feng, G., Zhang, X., Hu, Q., Sun, S., Sun, J., et al. (2021) The Functional Role of Lactoferrin in Intestine Mucosal Immune System and Inflammatory Bowel Disease. Frontiers in Nutrition, 8, Article 759507. https://doi.org/10.3389/fnut.2021.759507
Moreno-Expósito, L., Illescas-Montes, R., Melguizo-Rodríguez, L., Ruiz, C., Ramos-Torrecillas, J. and de Luna-Bertos, E. (2018) Multifunctional Capacity and Therapeutic Potential of Lactoferrin. Life Sciences, 195, 61-64. https://doi.org/10.1016/j.lfs.2018.01.002
Li, Q., Hu, W., Zhao, J., Wang, J., Dai, Y., Zhao, Y., et al. (2014) Supplementation Transgenic Cow’s Milk Containing Recombinant Human Lactoferrin Enhances Systematic and Intestinal Immune Responses in Piglets. Molecular Biology Reports, 41, 2119-2128. https://doi.org/10.1007/s11033-014-3061-5
Ochoa, T.J., Chea-Woo, E., Baiocchi, N., Pecho, I., Campos, M., Prada, A., et al. (2013) Randomized Double-Blind Controlled Trial of Bovine Lactoferrin for Prevention of Diarrhea in Children. The Journal of Pediatrics, 162, 349-356. https://doi.org/10.1016/j.jpeds.2012.07.043
Dix, C. and Wright, O. (2018) Bioavailability of a Novel Form of Microencapsulated Bovine Lactoferrin and Its Effect on Inflammatory Markers and the Gut Microbiome: A Pilot Study. Nutrients, 10, Article No. 1115. https://doi.org/10.3390/nu10081115
Sanjabi, S., Zenewicz, L.A., Kamanaka, M. and Flavell, R.A. (2009) Anti-Inflammatory and Pro-Inflammatory Roles of TGF-β, IL-10, and IL-22 in Immunity and Autoimmunity. Current Opinion in Pharmacology, 9, 447-453. https://doi.org/10.1016/j.coph.2009.04.008
Rébé, C., Végran, F., Berger, H. and Ghiringhelli, F. (2013) STAT3 Activation: A Key Factor in Tumor Immunoescape. Jakstat, 2, e23010. https://doi.org/10.4161/jkst.23010
Korn, T., Bettelli, E., Oukka, M. and Kuchroo, V. K. (2009) IL-17 and Th17 Cells. Annual Review of Immunology, 27, 485-517. https://doi.org/10.1146/annurev.immunol.021908.132710
Ihara, S., Hirata, Y. and Koike, K. (2017) TGF-β in Inflammatory Bowel Disease: A Key Regulator of Immune Cells, Epithelium, and the Intestinal Microbiota. Journal of Gastroenterology, 52, 777-787. https://doi.org/10.1007/s00535-017-1350-1
Barbaro, M.R., Di Sabatino, A., Cremon, C., Giuffrida, P., Fiorentino, M., Altimari, A., et al. (2016) Interferon-γ Is Increased in the Gut of Patients with Irritable Bowel Syndrome and Modulates Serotonin Metabolism. American Journal of Physiology-Gastrointestinal and Liver Physiology, 310, G439-G447. https://doi.org/10.1152/ajpgi.00368.2015
Bashier Eltayeb, L., Shams, D., Babikr, N., Madani, M., Abdelghani, S. and Ali Waggiallah, H. (2020) Serum Levels of Interferon Gamma INF-γ and Interleukin 10 Il-10: An Immunological Aspect among Irritable Bowel Syndrome Patients. Pakistan Journal of Biological Sciences, 23, 898-903. https://doi.org/10.3923/pjbs.2020.898.903
Lee, S.H., Kwon, J.Y., Kim, S.-Y., Jung, K. and Cho, M.-L. (2017) Interferon-Gamma Regulates Inflammatory Cell Death by Targeting Necroptosis in Experimental Autoimmune Arthritis. Scientific Reports, 7, Article No. 10133. https://doi.org/10.1038/s41598-017-09767-0
Mühl, H. and Pfeilschifter, J. (2003) Anti-Inflammatory Properties of Pro-Inflammatory Interferon-γ. International Immunopharmacology, 3, 1247-1255. https://doi.org/10.1016/S1567-5769(03)00131-0
Miller, N., Wang, J., Tan, Y. and Dittel, B. (2015) Anti-Inflammatory Mechanisms of IFN-γ Studied in Experimental Autoimmune Encephalomyelitis Reveal Neutrophils as a Potential Target in Multiple Sclerosis. Frontiers in Neuroscience, 9, Article 287. https://doi.org/10.3389/fnins.2015.00287
Zhang, J. (2007) Yin and Yang Interplay of IFN-γ in Inflammation and Autoimmune Disease. Journal of Clinical Investigation, 117, 871-873. https://doi.org/10.1172/JCI31860
Luckett-Chastain, L.R. and Gallucci, R.M. (2009) Interleukin (IL)-6 Modulates Transforming Growth Factor-β Expression in Skin and Dermal Fibroblasts from IL-6-Deficient Mice. British Journal of Dermatology, 161, 237-248. https://doi.org/10.1111/j.1365-2133.2009.09215.x
Vitetta, L., Briskey, D., Hayes, E., Shing, C. and Peake, J. (2012) A Review of the Pharmacobiotic Regulation of Gastrointestinal Inflammation by Probiotics, Commensal Bacteria and Prebiotics. Inflammopharmacology, 20, 251-266. https://doi.org/10.1007/s10787-012-0126-8
Demir, E., Ozkan, H., Seckin, K.D., Sahtiyanci, B., Demir, B., Tabak, O., et al. (2019) Plasma Zonulin Levels as a Non-Invasive Biomarker of Intestinal Permeability in Women with Gestational Diabetes Mellitus. Biomolecules, 9, Article No. 24. https://doi.org/10.3390/biom9010024
Fasano, A. (2012) Zonulin, Regulation of Tight Junctions, and Autoimmune Diseases. Annals of the New York Academy of Sciences, 1258, 25-33. https://doi.org/10.1111/j.1749-6632.2012.06538.x
Vanuytsel, T., Vermeire, S. and Cleynen, I. (2013) The Role of Haptoglobin and Its Related Protein, Zonulin, in Inflammatory Bowel Disease. Tissue Barriers, 1, e27321. https://doi.org/10.4161/tisb.27321